Roche Holding Ag Stock Performance
| RHHBF Stock | USD 365.00 0.46 0.13% |
On a scale of 0 to 100, Roche Holding holds a performance score of 9. The company holds a Beta of -0.69, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Roche Holding are expected to decrease at a much lower rate. During the bear market, Roche Holding is likely to outperform the market. Please check Roche Holding's coefficient of variation, maximum drawdown, skewness, as well as the relationship between the total risk alpha and downside variance , to make a quick decision on whether Roche Holding's historical price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Roche Holding AG are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, Roche Holding reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 5.7 B | |
| Total Cashflows From Investing Activities | -6.6 B |
Roche |
Roche Holding Relative Risk vs. Return Landscape
If you would invest 30,350 in Roche Holding AG on December 22, 2024 and sell it today you would earn a total of 6,150 from holding Roche Holding AG or generate 20.26% return on investment over 90 days. Roche Holding AG is currently producing 0.3533% returns and takes up 3.0408% volatility of returns over 90 trading days. Put another way, 27% of traded otc stocks are less volatile than Roche, and 93% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Roche Holding Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Roche Holding's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Roche Holding AG, and traders can use it to determine the average amount a Roche Holding's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1162
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RHHBF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.04 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.35 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Roche Holding is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Roche Holding by adding it to a well-diversified portfolio.
Roche Holding Fundamentals Growth
Roche OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Roche Holding, and Roche Holding fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Roche OTC Stock performance.
| Return On Equity | 0.45 | |||
| Return On Asset | 0.15 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 287.91 B | |||
| Shares Outstanding | 106.69 M | |||
| Price To Earning | 21.63 X | |||
| Price To Book | 11.61 X | |||
| Price To Sales | 4.11 X | |||
| Revenue | 62.8 B | |||
| EBITDA | 22.26 B | |||
| Cash And Equivalents | 6.81 B | |||
| Cash Per Share | 8.50 X | |||
| Total Debt | 16.08 B | |||
| Debt To Equity | 1.00 % | |||
| Book Value Per Share | 35.03 X | |||
| Cash Flow From Operations | 20.98 B | |||
| Earnings Per Share | 19.18 X | |||
| Total Asset | 92.32 B | |||
| Retained Earnings | 25.51 B | |||
| Current Asset | 26.61 B | |||
| Current Liabilities | 24.46 B | |||
About Roche Holding Performance
By analyzing Roche Holding's fundamental ratios, stakeholders can gain valuable insights into Roche Holding's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Roche Holding has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Roche Holding has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HOLDINGS operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 100920 people.Things to note about Roche Holding AG performance evaluation
Checking the ongoing alerts about Roche Holding for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Roche Holding AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Roche Holding AG had very high historical volatility over the last 90 days | |
| About 75.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Roche Holding's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Roche Holding's stock is overvalued or undervalued compared to its peers.
- Examining Roche Holding's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Roche Holding's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Roche Holding's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Roche Holding's otc stock. These opinions can provide insight into Roche Holding's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Roche OTC Stock analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets |